The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumShort Ideas - Seattle Genetics (NASDAQ:SGEN) missed earnings expectations again, leaving analysts and investors uncertain about the company’s 2012 revenue guidance and beyond. Major shareholders may seek to … Continue Reading
Read now- Salix Pharmaceuticals (NASDAQ:SLXP) is moving ahead of the bell after it announced 2Q earnings and a major licensing deal yesterday. Salix entered into an agreement … Continue Reading
Read nowLong Ideas - Sucampo Pharmaceuticals (NASDAQ:SCMP) reported 2Q 2012 revenues of $16.7 million, up 19.2% year over year. Evidence that the company’s treatment for irritable bowel syndrome (IBS), … Continue Reading
Read now- Bristol-Myers Squibb (NYSE:BMY) officially completed purchase of Amylin Pharmaceuticals (NASDAQ:AMLN) yesterday. The acquisition was completed without shareholder approval after BMY purchased additional AMLN shares directly … Continue Reading
Read now- Shares of drug-maker Warner Chilcott (NASDAQ:WCRX) are trading in immense volume today, nearly 5x daily average, and pushing the stock price down by 5%. The … Continue Reading
Read nowLong Ideas - The recent sharp decline in Halozyme Therapeutics (NASDAQ:HALO) last week in fact presented a major buying opportunity for investors, with the shares up roughly 57% … Continue Reading
Read nowShort Ideas - Shares of Seattle Genetics (NASDAQ:SGEN) have traded progressively higher this year, but tonight the rubber could meet the road if reported sales of lead cancer … Continue Reading
Read now
